Clinical Trials on Relapsed Malignant Mesothelioma in Switzerland

Total 776 results

Swiss Group for Clinical Cancer Research

Completed

Combination Chemotherapy Before Surgery in Treating Patients With Mesothelioma of the Lung

Malignant Mesothelioma

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Lurbinectedin Monotherapy in Patients With Progressive Malignant Pleural Mesothelioma.

Malignant Pleural Mesothelioma, Advanced

Switzerland, Italy
University of Zurich
Swiss National Science Foundation; Swiss Accident Insurance Fund SUVA

Completed

Intracavitary Cisplatin-Fibrin Localized Chemotherapy After P/D or EPP for Malignant Pleural Mesothelioma

Malignant Pleural Mesothelioma

Switzerland
European Organisation for Research and Treatment...
ETOP IBCSG Partners Foundation

Completed

SPECTAlung: Screening Patients With Thoracic Tumors for Efficient Clinical Trial Access (SPECTAlung)

Any Stage of Lung Cancer (Any Histotype) | Any Stage of Malignant Pleural Mesothelioma | Any Stage of Any Thymic Malignancy

Spain, Belgium, Ireland, Slovenia, France, United Kingdom, Poland, Italy, Switzerland
University of Zurich

Completed

Re-directed T Cells for the Treatment (FAP)-Positive Malignant Pleural Mesothelioma

Malignant Pleural Mesothelioma

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma

Malignant Mesothelioma

Switzerland, Germany
ETOP IBCSG Partners Foundation
Merck Sharp & Dohme LLC; Frontier Science Foundation, Hellas

Completed

PembROlizuMab Immunotherapy Versus Standard Chemotherapy for Advanced prE-treated Malignant Pleural Mesothelioma (PROMISE-meso)

Pleural Mesothelioma Malignant Advanced

United Kingdom, Switzerland, Spain
ETOP IBCSG Partners Foundation
Hoffmann-La Roche

Active, not recruiting

BEAT-meso: Bevacizumab and Atezolizumab in Malignant Pleural Mesothelioma (BEAT-meso)

Pleural Mesothelioma Malignant Advanced

Switzerland, United Kingdom, Belgium, Spain, France, Italy
Swiss Group for Clinical Cancer Research

Active, not recruiting

SAKK 17/18 (ORIGIN) MPM & NSCLC >1st Line Gemci & Atezo Ph II

Non-small Cell Lung Cancer | Malignant Pleural Mesothelioma

Switzerland
Genzyme, a Sanofi Company

Terminated

An Efficacy and Safety Study With Vandetanib to Treat Inoperable or Relapsed Malignant Mesothelioma

Mesothelioma

Germany, Switzerland
European Organisation for Research and Treatment...

Completed

Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura

Malignant Mesothelioma

Canada, France, Switzerland, Belgium, Netherlands, Italy, United Kingdom, Egypt, Germany, Peru, Poland
Dr Jean Yannis PERENTES

Recruiting

Treatment Pleural Carcinosis of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin Administration (PITHAC)

Carcinoma, Non-Small-Cell Lung | Gastric Cancer | Esophageal Cancer | Ovarian Cancer | Mesothelioma, Malignant | Carcinoma Breast Stage IV

Switzerland
AstraZeneca

Recruiting

MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma (eVOLVE-Meso)

Unresectable Pleural Mesothelioma

Denmark, Italy, Australia, Korea, Republic of, Belgium, Poland, United States, Canada, Japan, United Kingdom, Spain, China, France, Taiwan, Norway, Brazil, Germany, Switzerland, South Africa, Turkey, Netherlands
Novartis Pharmaceuticals

Recruiting

A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors

Mesothelioma

Australia, Switzerland, Italy, Spain, Canada, Germany, Japan, United Kingdom, Netherlands, United States, France
Bristol-Myers Squibb
Ono Pharmaceutical Co. Ltd

Completed

Study of Nivolumab Combined With Ipilimumab Versus Pemetrexed and Cisplatin or Carboplatin as First Line Therapy in Unresectable Pleural Mesothelioma Patients (CheckMate743)

Mesothelioma

Brazil, United States, China, Italy, Australia, Belgium, Chile, Colombia, France, Germany, Greece, Japan, Mexico, Netherlands, Poland, Romania, Russian Federation, South Africa, Switzerland, Turkey, United Kingdom
Kantonsspital Winterthur KSW

Completed

Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program

Renal Cell Carcinoma | Breast Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Urothelial Carcinoma | Pleural Mesothelioma | Gastro-Intestinal Cancer

Switzerland
Rolf Inderbitzi
Clinical Trial Unit Ente Ospedaliero Cantonale

Unknown

Malignant Pleural Effusion: Pleur-X vs. Chemical Pleurodesis in VATS (Pleur-X)

Malignant Pleural Effusion

Switzerland
Kantonsspital Liestal

Completed

Feasibility, Safety and QoL After Merendino Procedure (MER)

Benign or Early Malignant Lesion of the Distal Esophagus or Gastro-esophageal Junction Requiring Surgical Resection

Switzerland
Sequana Medical N.V.

Completed

Retrospective Study in the Use of the Alfapump and the Treatment of Malignant Ascites

Malignant Ascites

Germany, Switzerland, United Kingdom
Cytos Biotechnology AG

Completed

Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients

Malignant Melanoma

Switzerland
Hoffmann-La Roche

Completed

A Pharmacokinetic and Metabolism Study of 14C-labeled RO5185426 on Patients With Metastatic Melanoma

Malignant Melanoma

Switzerland
Sequana Medical N.V.

Recruiting

International Alfapump Cohort Study (TOPMOST)

Liver Cirrhoses | Malignant Ascites

Germany, Switzerland
Markus Joerger

Recruiting

Tinostamustine and Nivolumab in Advanced Melanoma (ENIgMA)

Malignant Melanoma

Switzerland
Cytos Biotechnology AG

Completed

Safety and Immunogenicity of a Melan-A VLP Vaccine in Early Stage Melanoma Patients

Malignant Melanoma

Switzerland
University of Zurich

Unknown

Associating Liver Partition With Portal Vein Ligation for Staged Hepatectomy (ALPPS) vs. Two-Stage Hepatectomy (TSH) for Marginally Resectable Colorectal Liver Metastases (CRLM) (ALPPSforCRLM)

Liver Diseases | Liver Neoplasms | Hepatectomy | Surgery | Secondary Malignant Neoplasm of Liver | Colon Cancer Liver Metastases | Malignant Neoplasm of Large Intestine Metastatic to Liver

Switzerland
University Children's Hospital, Zurich

Completed

Magnetic Resonance (MR) Guided Focused Ultrasound in the Treatment of Brain Tumors (FUS-Tumor)

Malignant Brain Tumors

Switzerland
Thomas Zilli
University Hospital, Geneva

Recruiting

Total Marrow Irradiation With Volumetric Arc Therapy for Patients Unfit for a 12 Gy TBI

Haematological Malignancy

Switzerland
Cytos Biotechnology AG

Completed

Safety and Immunogenicity of CYT004-MelQbG10 Vaccine With and Without Adjuvant in Advanced Stage Melanoma Patients

Malignant Melanoma

Switzerland
University Hospital Inselspital, Berne

Active, not recruiting

CD34+ Selected ASCT for Aggressive Lymphomas (SAAL)

Malignant Non-Hodgkin Lymphomas

Switzerland
Centre Hospitalier Universitaire Vaudois

Terminated

Photo-induction as a Means to Improve Cisplatin Delivery to Pleural Malignancies (PDT-lipo)

Pleural Effusion, Malignant

Switzerland
Centre Hospitalier Universitaire Vaudois

Recruiting

Irradiation of Melanoma in a Pulse (IMPulse)

Metastasis From Malignant Melanoma of Skin (Diagnosis)

Switzerland
Cantonal Hospital of St. Gallen
University Hospital, Geneva; University Hospital Muenster; Stanford University; University of Toronto and other collaborators

Recruiting

Microsurgical Resection of Intramedullary Spinal Cord Metastases

Spinal Cord Neoplasms | Radiotherapy; Complications | Functional Outcome | Spinal Cord Metastasis | Spinal Cord Tumor Malignant Intramedullary

Switzerland
Hoffmann-La Roche

Completed

A Study of RO5185426 in Previously Treated Melanoma Patients With Brain Metastases

Malignant Melanoma

Switzerland
Prof. Dominique de Quervain, MD
Psychiatric Hospital of the University of Basel

Terminated

Effects of Glucocorticoids on Craving During Detoxification Treatment of Heroin and/or Stimulants (Goliath)

Opioid Dependence | Cocaine Dependence

Switzerland
University Hospital Inselspital, Berne

Completed

Lymph Node Identification in Skin Malignancy Using ICG Transcutaneously Study (LIMIT)

Merkel Cell Carcinoma | Malignant Melanoma

Switzerland
University Hospital, Basel, Switzerland

Completed

Interaction Between Reboxetine and 3,4-Methylenedioxymethamphetamine: Pharmacodynamics (PD) and Pharmacokinetics (PK)

Substance-related Disorders | Mood Disorder | Amphetamine-related Disorders

Switzerland
Prof. Dominique de Quervain, MD

Completed

Acute Effects of Cortisol on Heroin Craving in Opioid Dependence (Ghost-Basel) (Ghost-Basel)

Opioid Dependence

Switzerland
University Hospital, Basel, Switzerland
Psychiatric Hospital of the University of Basel

Completed

PHAST: Physical Activity in Substitution Therapy (PHAST)

Substance-related Disorders

Switzerland
University of Bern

Completed

Telephone-Based Continuing Care for Alcohol Dependence

Alcohol Dependence

Switzerland
Psychiatric University Hospital, Zurich

Unknown

Transfer From Methadone to Buprenorphine Maintenance Treatment Using Buprenorphine Patches

Heroin Addiction

Switzerland
University Hospital, Basel, Switzerland

Completed

Pharmacological Interaction Between Carvedilol and Methylenedioxymethamphetamine (MDMA)

Substance-Related Disorders | Amphetamine-Related Disorders | Mood Disorder

Switzerland
University Hospital, Basel, Switzerland
Heffter Research Institute

Completed

Pharmacological Interaction Between Pindolol and MDMA (3,4-Methylenedioxymethamphetamine)

Substance-Related Disorders | Amphetamine-Related Disorders | Mood Disorder

Switzerland
Sequana Medical N.V.

Completed

ALFApump System Post Marketing Surveillance Registry (2011-AAR-004)

Liver Cirrhosis | Malignant Ascites | Refractory Ascites

Germany, Switzerland, Spain, United Kingdom
University Hospital, Basel, Switzerland

Completed

Prize Reinforcement Contingency Management for Cocaine Dependence: a 24-week Randomized Controlled Trial

Cocaine-related Disorders

Switzerland
University Hospital, Basel, Switzerland

Completed

Pharmacological Interaction Between Clonidine and Methylenedioxymethamphetamine (MDMA)

Substance-Related Disorders | Amphetamine-Related Disorders | Mood Disorder

Switzerland
European Paediatric Soft Tissue Sarcoma Study Group
Children's Cancer and Leukaemia Group; Dutch Childhood Oncology Group; Italian... and other collaborators

Unknown

Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma

Sarcoma | Childhood Malignant Fibrous Histiocytoma of Bone

Ireland, United Kingdom, Spain, Austria, Belgium, Denmark, France, Sweden, Switzerland
University Hospital Inselspital, Berne

Completed

The Role of Macular Pigment in Patients With Age-related Macular Degeneration

Age Related Maculopathy

Switzerland
University Hospital Inselspital, Berne

Completed

Enhancement of Macular Pigment Density by Oral Lutein Supplementation (EMPOLS)

Age-Related Maculopathies

Switzerland
University Hospital, Basel, Switzerland

Completed

Pharmacological Interaction Between Doxazosin and Methylenedioxymethamphetamine (MDMA)

Substance-Related Disorders | Amphetamine-Related Disorders | Mood Disorder

Switzerland
University Hospital, Basel, Switzerland

Completed

Interaction Between Duloxetine and 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy)

Substance-Related Disorders | Amphetamine-Related Disorders | Mood Disorder

Switzerland

Clinical Trials on Relapsed Malignant Mesothelioma in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Venezuela

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations